Aldeyra Therapeutics Inc. buy marge
Start price
28.09.18
/
50%
€12.09
Target price
30.07.19
€17.14
Performance (%)
-58.96%
End price
30.07.19
€4.96
Summary
This prediction ended on 30.07.19 with a price of €4.96. The BUY prediction by marge for Aldeyra Therapeutics Inc. performed very badly with a performance of -58.96%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aldeyra Therapeutics Inc. | 11.111% | 11.111% | -35.703% | -82.546% |
| iShares Core DAX® | 1.352% | 0.930% | 6.806% | 52.447% |
| iShares Nasdaq 100 | 3.277% | 4.990% | 41.197% | 93.454% |
| iShares Nikkei 225® | 7.434% | 16.599% | 70.505% | 80.899% |
| iShares S&P 500 | 1.702% | 2.244% | 27.281% | 67.688% |
Comments by marge for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von stratec zu
marge stimmt am 28.09.2018 der Buy-Einschätzung von stratec mit dem Kursziel 19$ zu.
Überschrift: Aldeyra multiple trials are set to read out in the second half of the year
(Vom Mitglied beendet)